|
US8263402B1
(en)
*
|
1998-10-19 |
2012-09-11 |
Cornell Research Foundation, Inc. |
Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
|
|
US7410798B2
(en)
|
2001-01-10 |
2008-08-12 |
Geron Corporation |
Culture system for rapid expansion of human embryonic stem cells
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
US20050042749A1
(en)
|
2001-05-16 |
2005-02-24 |
Carpenter Melissa K. |
Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
|
|
US7250294B2
(en)
|
2000-05-17 |
2007-07-31 |
Geron Corporation |
Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
|
|
EP1287116A2
(en)
|
2000-05-17 |
2003-03-05 |
Geron Corporation |
Neural progenitor cell populations
|
|
US6897061B1
(en)
*
|
2000-06-16 |
2005-05-24 |
Spinal Cord Society |
Transdifferentiation of glial cells
|
|
US20030223972A1
(en)
|
2002-02-15 |
2003-12-04 |
Goldman Steven A. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
US7207743B2
(en)
*
|
2002-05-28 |
2007-04-24 |
Polivka Parking Solutions Llc |
Method and apparatus for constructing an automotive vehicle parking lot
|
|
US7285415B2
(en)
|
2002-07-11 |
2007-10-23 |
The Regents Of The University Of California |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
US20050101014A1
(en)
|
2002-07-11 |
2005-05-12 |
Keirstead Hans S. |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
AR046076A1
(es)
*
|
2003-07-18 |
2005-11-23 |
Otsuka Pharma Co Ltd |
Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida
|
|
EP1682075A4
(en)
*
|
2003-11-07 |
2009-12-09 |
Univ Florida |
BREEDING AND DIFFERENTIATION OF NEURAL CREATOR CELLS
|
|
AU2005209169B2
(en)
|
2004-01-16 |
2010-12-16 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
|
AU2005252434B2
(en)
*
|
2004-06-09 |
2011-11-24 |
The University Court Of The University Of Edinburgh |
Neural stem cells
|
|
CN101106955A
(zh)
*
|
2005-01-19 |
2008-01-16 |
菲迪亚高级生物聚合物有限公司 |
用于sci和pnt再生的透明质酸衍生物和神经干细胞
|
|
WO2008020815A1
(en)
|
2006-08-15 |
2008-02-21 |
Agency For Science, Technology And Research |
Mesenchymal stem cell conditioned medium
|
|
US7803364B2
(en)
|
2005-11-17 |
2010-09-28 |
The Cleveland Clinic Foundation |
Multipotent neural stem cells
|
|
WO2007120911A2
(en)
*
|
2006-04-14 |
2007-10-25 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
|
EP2012832A2
(en)
*
|
2006-04-14 |
2009-01-14 |
Celsense, Inc. |
Methods for assessing cell labeling
|
|
US8163075B2
(en)
|
2006-10-31 |
2012-04-24 |
Sensient Colors Llc |
Inks comprising modified pigments and methods for making and using the same
|
|
US20100119493A1
(en)
*
|
2007-04-17 |
2010-05-13 |
University Of Rochester |
Telencephalic Glial-Restricted Cell Populations and Related Compositions and Methods
|
|
CA2693678C
(en)
*
|
2007-07-10 |
2017-02-14 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
|
AU2008288785B2
(en)
|
2007-08-23 |
2014-08-21 |
Sensient Colors Inc. |
Self-dispersed pigments and methods for making and using the same
|
|
CN101939362A
(zh)
|
2008-01-30 |
2011-01-05 |
杰龙公司 |
用于培养干细胞衍生的少突胶质细胞前体细胞的合成表面
|
|
WO2009116951A2
(en)
|
2008-03-17 |
2009-09-24 |
Agency For Science, Technology And Research |
Microcarriers for stem cell culture
|
|
WO2009134435A2
(en)
*
|
2008-05-02 |
2009-11-05 |
Celsense Inc. |
Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
|
|
US9709553B2
(en)
|
2008-05-08 |
2017-07-18 |
University Of Rochester |
Treating myelin diseases with optimized cell preparations
|
|
US9688956B2
(en)
|
2008-06-05 |
2017-06-27 |
National Cheng Kung University |
Method for preserving proliferation and differentiation potential of mesenchymal stem cells
|
|
WO2010008486A2
(en)
|
2008-06-24 |
2010-01-21 |
Parkinsons Institute |
Pluripotent cell lines and methods of use thereof
|
|
US20110236356A1
(en)
*
|
2008-12-12 |
2011-09-29 |
Nova Southeastern University |
Methods of isolating and using stem cells
|
|
CN102325878A
(zh)
|
2008-12-23 |
2012-01-18 |
斯特姆塞尔思加利福尼亚有限公司 |
少突胶质前体细胞的靶向细胞群及制备与使用方法
|
|
KR20110135989A
(ko)
|
2009-04-07 |
2011-12-20 |
센션트 컬러스 엘엘씨 |
자가-분산 입자 및 그의 제조 및 사용 방법
|
|
AU2010276264B2
(en)
|
2009-07-21 |
2013-09-19 |
Abt Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
|
SG10201404280XA
(en)
|
2009-07-21 |
2014-10-30 |
Abt Holding Co |
Use of stem cells to reduce leukocyte extravasation
|
|
WO2011096825A1
(en)
*
|
2010-02-05 |
2011-08-11 |
Auckland Uniservices Limited |
Cell programming
|
|
DK2539436T3
(da)
|
2010-02-25 |
2021-10-18 |
Abt Holding Co |
Modulering af makrofagaktivering
|
|
US9725689B2
(en)
|
2010-10-08 |
2017-08-08 |
Terumo Bct, Inc. |
Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
|
US8433419B2
(en)
|
2010-10-13 |
2013-04-30 |
Cardiac Pacemakers, Inc. |
Method and apparatus for controlling neurostimulation according to physical state
|
|
WO2012168295A1
(en)
|
2011-06-06 |
2012-12-13 |
ReGenesys BVBA |
Expansion of stem cells in hollow fiber bioreactors
|
|
EP3766962B1
(en)
|
2013-02-06 |
2025-10-22 |
University of Rochester |
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
|
|
KR102057601B1
(ko)
|
2013-03-15 |
2019-12-19 |
웨이크 포리스트 유니버시티 헬스 사이언시즈 |
신경 전구 세포 분화
|
|
KR102161726B1
(ko)
|
2013-04-12 |
2020-10-06 |
사베리오 라프란체스카 |
이식용 장기의 개선
|
|
EP2992088B1
(en)
|
2013-04-30 |
2019-08-21 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
|
EP3068867B1
(en)
|
2013-11-16 |
2018-04-18 |
Terumo BCT, Inc. |
Expanding cells in a bioreactor
|
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
|
WO2017147212A1
(en)
|
2016-02-22 |
2017-08-31 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
|
CA3019514A1
(en)
|
2016-03-30 |
2017-10-05 |
Asterias Biotherapeutics, Inc. |
Oligodendrocyte progenitor cell compositions
|
|
AU2018215170B2
(en)
*
|
2017-01-31 |
2021-11-11 |
Osaka University |
Differentiation control method for pluripotent stem cells
|
|
EP3621434B1
(en)
|
2017-05-10 |
2026-07-15 |
University of Rochester |
Glial progenitor cells for use in treating schizophrenia
|
|
AU2019342741B2
(en)
|
2018-09-19 |
2025-12-11 |
Lineage Cell Therapeutics, Inc. |
Methods for differentiating pluripotent stem cells in dynamic suspension culture
|
|
AU2020210757B2
(en)
*
|
2019-01-23 |
2026-04-16 |
Asterias Biotherapeutics, Inc. |
Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
|
|
JP7728747B2
(ja)
|
2019-08-23 |
2025-08-25 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃｄ２４発現細胞およびそれらの用途
|
|
EP4125961A1
(en)
|
2020-03-25 |
2023-02-08 |
Sana Biotechnology, Inc. |
Hypoimmunogenic neural cells for the treatment of neurological disorders and conditions
|
|
AU2021325941A1
(en)
|
2020-08-13 |
2023-03-09 |
Sana Biotechnology, Inc. |
Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
|
|
US20240226164A1
(en)
|
2021-05-27 |
2024-07-11 |
Sana Biotechnology, Inc. |
Hypoimmunogenic cells comprising engineered hla-e or hla-g
|
|
CA3225283A1
(en)
|
2021-07-14 |
2023-01-19 |
Sonja SCHREPFER |
Altered expression of y chromosome-linked antigens in hypoimmunogenic cells
|
|
AU2022325231A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
|
|
AU2022325955A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
|
|
US20260053851A1
(en)
|
2021-08-11 |
2026-02-26 |
Sana Biotechnology, Inc. |
Inducible systems for altering gene expression in hypoimmunogenic cells
|
|
AU2022326565A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
|
WO2023183313A1
(en)
|
2022-03-22 |
2023-09-28 |
Sana Biotechnology, Inc. |
Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods
|
|
WO2025054202A1
(en)
|
2023-09-05 |
2025-03-13 |
Sana Biotechnology, Inc. |
Method of screening a sample comprising a transgene with a unique barcode
|
|
WO2025061158A1
(zh)
|
2023-09-20 |
2025-03-27 |
士泽生物医药（苏州）有限公司 |
一种表达mcl1的低免疫原性细胞及其制备方法
|
|
AU2025208175A1
(en)
|
2024-01-12 |
2026-06-25 |
Sana Biotechnology, Inc. |
Safety switches to control in vitro and in vivo proliferation of cell therapy products
|